PAREQ
LIVE

Serial Number

79092131

Owner

PAREQ AG

Attorney

PATRICIA A WALKER

Filing Date

Nov 11, 2010

Add to watchlist:

No watchlists yet
View on USPTO

PAREQ Trademark

Serial Number: 79092131 • Registration: 4223662

PAREQ is a trademark filed by PAREQ AG on November 11, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

PAREQ AG

c/o HS LifeSciences AG
40212 Düsseldorf , DE

Entity Type: 99

HS LifeSciences Ltd

Seehofstrasse 6
CH-8008 Zürich , CH

Entity Type: 03

Trademark Details

Filing Date

November 11, 2010

Registration Date

October 16, 2012

Published for Opposition

July 31, 2012

Cancellation Date

November 11, 2020

Goods & Services

Pharmaceutical and veterinary preparations and substances for immunotherapy, for the treatment of cancer, Alzheimer's disease and other diseases which can be treated or relieved or prevented by antibodies that bind to a target antigen or activate or block a target antigen

Chemical, biochemical, biological and biotechnological preparations, namely, antibodies and antibody particles for the development or production of immunological reagents for industrial and scientific use; biological preparations, namely, antibodies and antibody particles other than medical or veterinary use, namely, for use in laboratories, clinics, for diagnosis and analysis and all for scientific or scientific research use; carriers and substances, namely, chemical additives, plasticizers and all for use in the production of pharmaceutical preparations; chemical, biochemical, biological and biotechnological preparations for industrial and scientific use, namely, for use in the development of pharmaceutical preparations and in biotechnology, namely, antibodies and antibody particles

Biological and medical research; technological research in the fields of pharmaceuticals and biotechnology; laboratory service, namely, medical laboratories; biological and biotechnological analyses; discovery and development of active substances, namely, pharmaceutical drug discovery and development services; medical and scientific research in the field of identifying, characterizing and developing antibodies

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 7, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 7, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 8, 2020 INTS
INVALIDATION PROCESSED
Feb 8, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 17, 2020 INTR
CANCELLED SECTION 71
May 17, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 16, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 19, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 4, 2013 FICS
FINAL DISPOSITION PROCESSED
Feb 4, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 16, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Sep 22, 2012 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 31, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jul 31, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 22, 2012 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 11, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 11, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 11, 2012 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 4, 2012 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 4, 2012 OPNR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 26, 2012 PREV
ASSIGNED TO LIE
Jun 26, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
May 17, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 17, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
May 17, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 17, 2012 CNEA
CHANGE OF OWNER RECEIVED FROM IB
Apr 21, 2012 CHLD
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 4, 2011 GNFN
FINAL REFUSAL E-MAILED
Oct 4, 2011 GNFR
FINAL REFUSAL WRITTEN
Oct 4, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 1, 2011 TROA
REFUSAL PROCESSED BY IB
Mar 19, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 1, 2011 RFCS
REFUSAL PROCESSED BY MPU
Mar 1, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2011 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2011 CNRT
ASSIGNED TO EXAMINER
Feb 22, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 3, 2011 REPR